Article
Evolutionary druggability: leveraging low-dimensional fitness landscapes towards new metrics for antimicrobial applications
2023-04-08
Abstract excerpt
The term “druggability” describes the molecular properties of drugs or targets in pharmacological interventions and is commonly used in work involving drug development for clinical applications. There are no current analogues for this notion that quantify the drug-target interaction with respect to a given target variant’s sensitivity across a breadth of drugs in a panel, or a given drug’s range of effectiveness a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5b56cec4-67bb-5d43-ba29-32c0d90e2ca2
- DOI
- 10.1101/2023.04.08.536116
